We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Nitroso

Nitrosamines are a group of chemical compounds that contain the nitroso functional group (NO) attached to an amine group (-NH). They can form in various ways, including through industrial processes, combustion, and certain chemical reactions, particularly involving nitrites and secondary amines. Nitrosamines are of concern because Many nitrosamines (N-Nitrosamines) are potent genotoxins; some have been classified as possible human carcinogens, although the degree of risk can vary depending on factors such as the amount of exposure and individual susceptibility. Synchemia Research Chemical is dedicated to thoroughly investigating the formation of nitroso impurities in APIs, including those related to the manufacturing processes. This approach indicates a proactive stance toward quality control and regulatory compliance. By exploring all potential sources of nitroso impurities, including those arising from the production processes themselves, Synchemia Research Chemical demonstrates a commitment to ensuring the purity, safety, and efficacy of their pharmaceutical products. Nitrosoamines, including N-Des-methyl Nitroso impurities, are important in pharmaceutical research and development due to their potential impact on drug safety and efficacy. Understanding and controlling the presence of these impurities is crucial for ensuring the quality and safety of pharmaceutical products. Can N-Nitrosamines exist in two different stable forms? N-nitrosamines substituted with two different alkyl groups can exist in two different stable forms distinguishable by several analytical methods. The two rotamers may differ in their overall dipole moment and therefore may posses different chemical and physical properties. Why do I see two peaks when analyzing N-Nitrosamines by HPLC or GC? HPLC and GC)analysis of N-nitrosamines may show two rotamers of the N-nitrosamine as two separate peaks. Whether two peaks are observed depends on the structure of the N-nitrosamine (i.e., symmetric vs. asymmetric) as well as the separation power of the analytical method.
We are the Synchemia Research Chemical specializes in manufacturing and exporting various nitrosoamine compounds, particularly focusing on N-Des-methyl Nitroso impurities of various APIs and nitroso compounds of direct APIs that contain secondary amines. By specializing in the synthesis and export of these compounds, Synchemia Research likely plays a significant role in supporting the pharmaceutical industry's efforts to meet regulatory requirements and ensure the highest standards of quality and safety in drug manufacturing.
download image Download catalogue

Pharmaceutical Reference Standards

Enasidenib Nitroso Impurity 1
Enasidenib Nitroso Impurity 1
CAT No SRC-N014494
CAS No NA
Mol.F. C19H16F6N8O2
Mol.Wt. 502.4
INV STATUS CUSTOM SYNTHESIS
Enasidenib Nitroso Impurity 2
Enasidenib Nitroso Impurity 2
CAT No SRC-N014495
CAS No NA
Mol.F. C19H15F6N9O3
Mol.Wt. 531.4
INV STATUS CUSTOM SYNTHESIS
Enasidenib Nitroso Impurity 3
Enasidenib Nitroso Impurity 3
CAT No SRC-N014496
CAS No NA
Mol.F. C19H16F6N8O2
Mol.Wt. 502.4
INV STATUS CUSTOM SYNTHESIS
Encorafenib Nitroso
Encorafenib Nitroso
CAT No SRC-N014497
CAS No NA
Mol.F. C22H26ClFN8O5S
Mol.Wt. 569.0
INV STATUS CUSTOM SYNTHESIS
Erdafitinib Nitroso
Erdafitinib Nitroso
CAT No SRC-N014498
CAS No NA
Mol.F. C25H29N7O3
Mol.Wt. 475.6
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Esmolol
N-Nitroso Esmolol
CAT No SRC-N014500
CAS No NA
Mol.F. C16H24N2O5
Mol.Wt. 324.4 g/mol
INV STATUS IN STOCK
N-Nitroso Etilefrine EP Impurity F
N-Nitroso Etilefrine EP Impurity F
CAT No SRC-N014501
CAS No N-Nitroso Etilefrine EP Impurity F
Mol.F. C9H12N2O
Mol.Wt. 164.2
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Etodolac
N-Nitroso Etodolac
CAT No SRC-N014502
CAS No NA
Mol.F. C17H20N2O4
Mol.Wt. 316.4 g/mol
INV STATUS UNDER SYNTHESIS
Etofenamate Nitroso
Etofenamate Nitroso
CAT No SRC-N014503
CAS No NA
Mol.F. C18H17F3N2O5
Mol.Wt. 398.3
INV STATUS CUSTOM SYNTHESIS
Etravirine Nitroso
Etravirine Nitroso
CAT No SRC-N014504
CAS No NA
Mol.F. C20H14BrN7O2
Mol.Wt. 464.3
INV STATUS CUSTOM SYNTHESIS

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.